Pro islet amyloid polypeptide (ProIAPP) immunoreactivity in the islets of langerhans

Upsala Journal of Medical Sciences

Volumn 105, Issue 2, 2000, Pages 97-106

  Westermark, Gunilla T ^a   Steiner, Donald F ^e   Gebre Medhin, Samuel ^b,d   Engström, Ulla ^c   Westermark, Per ^f  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Ludwig Institute of Cancer Research   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF CHICAGO   (United States)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; ANTISERUM; PROTEIN PRECURSOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; MOLECULAR GENETICS; MOUSE; PANCREAS ISLET; RABBIT;

AMINO ACID SEQUENCE; AMYLOID; ANIMALS; HUMANS; IMMUNE SERA; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; MICE; MOLECULAR SEQUENCE DATA; PROTEIN PRECURSORS; RABBITS;

EID: 0034573325     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Badman, M. K., Sherman, K. I., Jermany, J. L., Docherty, K. & Clark, A.: Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2. FEBS Lett 378:227-231, 1996.
2. Clark, A., Lloyd, J., Novials, A., Hutton, J. C. & Morris, J. F.: Localisation of islet amyloid polypeptide and its carboxy terminal flanking peptide in islets of diabetic man and monkey. Diabetologia 34:449-451, 1991.
3. Cooper, G. J., Willis, A. C., Clark, A., Turner, A. C., Sim, R. B. & Reid, K. B. M.: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628-8632, 1987.
4. Furuta, M., Carroll, R., Martin, S., Swift, H. H., Ravazzola, M., Orci, L. & Steiner, D. F.: Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem 273:3431-3437.
5. Gebre-Medhin, S., Mulder, H., Pekny, M., Westermark, G. T., Törnell, J., Westermark, P., Sundler, F., Ahrén, B. & Betsholtz, C.: Increased insulin secretion and and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun 250:271-277, 1998.
6. Gustavsson, Å., Engström, U. & Westermark, P.: Mechanisms of transthyretin (TTR) amyloidogenesis: antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Path 144:1301-1311, 1994.
7. Hull, R. L., Jaikaran, E. T., Serpell, L. C., Fraser, P. E., Clark, A. & Landon, M.: Synthetic human pro-islet amyloid polypeptide forms amyloid-like fibrils in vitro. Diabetologia 41 (Suppl. 1):A657 (abstr), 1998.
8. Janciauskiene, S., Eriksson, S., Carlemalm, E. & Ahrén, B.: B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun 236:580-585, 1997.
9. Janson, J., Ashley, R. H., Harrison, D., McIntyre, S. & Butler, P. C.: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491-498, 1999.
10. Jarrett ,J. T. & Lansbury, P. T.: Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058, 1993.
11. Karlsson, E.: IAPP as a regulator of glucose homeostasis and pancreatic hormone secretion. Int J Mol Med 3:577-584, 1999
12. Lipkind, G. & Steiner, D. F.: Predicted structural alterations in proinsulin during its interaction with prohormone convertases. Biochemistry 19:890-896, 1999.
13. Lorenzo, A., Razzaboni, B., Weir, G. C. & Yankner, B.A.: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756-760, 1994.
14. Ma, Z., Westermark, G. T., Li, Z.-C., Engström, U. & Westermark, P.: Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in the amyloidogenesis. Diabetologia 40:793-801, 1997.
15. Nishi, M., Bell, G. I. & Steiner, D. F.: Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:628-630, 1990.
16. Nishi, M., Sanke, T., Nagamatsu, S., Bell, G. I. & Steinder, D. F.: Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits. J Biol Chem 265:4173-4176, 1990.
17. O'Brien, T. D., Butler, A. E., Roche, P. C., Johnson, K. H. & Butler, P. C.: Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes 43:329-336, 1994.
18. Olsen, K. E., Sletten, K. & Westermark, P.: The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay. Am J Clin Path 111:355-362, 1999.
19. Puchtler, H., Sweat, F. & Levine, M.: On the binding of Congo red by amyloid. J Histochem Cytochem 10:355-364, 1962.
20. Sakagashira, S., Sanke, T., Hanabusa, T., Shimomura, H., Ohagi, S., Kumagaye, K. Y., Nakajima, K. & Nanjo, K.: Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 45:1279-1281, 1996.20.
21. Sletten, K., Westermark, P. & Natvig, J. B.: Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 143: 993-998, 1976.
22. Westermark, G. T., Johnson, K. H. & Westermark, P.: Staining Methods for Identification of Amyloid in Tissue. Meth Enzymol 309:3-25, 1999.
23. Westermark, G., Benig Arora, M., Fox, N., Carroll, R., Chan, S. J., Westermark, P. & Steiner, D. F.: Amyloid formation in response to b cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med 1:542-553, 1995,
24. Westermark, G. T., Gebre-Medhin, S., Steiner, D. F. & Westermark, P.: Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Submitted 2000.
25. Westermark, G. T., Westermark, P., Eizirik, D., Hellerström, C., Fox, N., Steiner, D. F. & Andersson, A.: Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice. Metabolism 48:448-454, 1999.
26. Westermark, P: Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch. A 359:1-18, 1973.
27. Westermark, P., Eizirik, D. L., Pipeleers, D. G., Hellerström, C., & Andersson, A.: Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38:543-549, 1995.
28. Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T. & Betsholtz, C.: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87:5036-5040, 1990.
29. Westermark, P., Engström, U., Westermark, G. T., Johnson, K. H., Permerth, J. & Betsholtz, C.: Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans. Diab Res Clin Pract 7:219-226, 1989.
30. Westermark, P., Li, Z.-C, Westermark, G.T., Leckström, A. & Steiner, D.F.: Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett 379:203-206, 1996.
31. Westermark, P., Wernstedt, C., O'Brien, T. D., Hayden, D. W. & Johnson, K. H.: Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Path 127:414-417, 1987.
32. Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T.D. & Johnson, K.H.: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84:3881-3885, 1987.
33. Westermark, P., Wernstedt, C., Wilander, E. & Sletten, K.: A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140:827-831, 1986.